WhiteBook2_Part2 - 49

Appendix
Simvastatin And Rifaximin as New Therapy For Patients With
Decompensated Cirrhosis
Targeted strategies for prevention and treatment of fibrosis-associated
liver cancer
Targeting ubiquitin processing in cancer and fibrosis: novel probes for
the Ubiquitin Carboxy-Terminal Hydrolases
The HepaRG-Bio-Artificial Liver: Feasibility of commercialization and
expansion of business plan
The N-IF mouse - a new and unique fibrosis model for preclinical efficacy
studies
Tracking the Dynamics of Human Metabolism using SpectroscopyIntegrated
Liver-on-Chip Microdevices
Treatment of liver disease and cancer prevention
Understanding the Biology of Human Enteroendocrine Cells
Development of New therapies against cholangiopathies
Perivascular cells at the crossroads of inflammation, regeneration and
fibrosis
A Revolutionary, Safe and Cost-effective Industrial Process for Gluten
Detoxification in Cereals
A study for the technical and business feasibility of a fast-acting
consumer test to detect gluten and other contaminants in food.
Human Exposomic Determinants of Immune Mediated Diseases
Improving Gluten-Free Flours Functionality by MW Treatments; A Tool
for High Quality of Gluten-Free Bakery (Physical, Sensorial and
Nutritional)
Leveraging a novel platform technology to develop a first-in-class
immunotherapy for Celiac Disease
Smart Technologies for personAlised Nutrition and Consumer
Engagement
Therapeutic potential of recombinant antibodies to neutralize
immunogenic peptides in celiac disease
Using a blood cell-based approach to determine gluten responsiveness
and to bring a novel, less invasive assay on the market to diagnose celiac
disease.
The Role of Mucins and Mucus in the Diseases Cystic Fibrosis, Celiac
Disease, and Ulcerative Colitis
A novel drug candidate for the treatment of Eosinophilic Esophagitis - an
innovative solution for a significant unmet medical need
Characterization of the Human Gallbladder Microbiome
Recurrent disease in the liver transplant: window to identify and stop gut
signals driving autoimmunity
The first multiple stent delivery system for the treatment of biliary,
pancreatic and urologic strictures and stenosis
A minimally invasive, outpatient treatment for Gastroesophageal Reflux
Disease (GERD), resulting in permanent relief from both GERD symptoms
and life-long drug dependency
A novel ulcerative colitis treatment - A phase III ready feasibility study
5998800
2430000
224933.76
50000
50000
2118175
150000
2733150
2499111
Chronic liver
diseases
Chronic liver
diseases
Chronic liver
diseases
Chronic liver
diseases
Chronic liver
diseases
Chronic liver
diseases
Chronic liver
diseases
Chronic liver
diseases
Chronic liver
diseases and
Gallbladder and
biliary diseases
1976100
1265192
50000
11992338.74
170121.6
50000
6393914
160932.48
130062.5
2500000
50000
187866
1500000
50000
50000
50000
Chronic liver
diseases and
Inflammatory
bowel disease
Coeliac disease
Coeliac disease
Coeliac disease
Coeliac disease
Coeliac disease
Coeliac disease
Coeliac disease
Coeliac disease
Coeliac disease
and Inflammatory
bowel disease
Eosinophilic
oesophagitis
Gallbladder and
biliary diseases
Gallbladder and
biliary diseases
Gallbladder and
biliary diseases
Gastroesophageal
reflux disease
Inflammatory
bowel disease
White Book 2: Part 2
46
WhiteBook2_Part2

Table of Contents for the Digital Edition of WhiteBook2_Part2
